BioClinica Announces Its Tender Offer is Complete

BioClinica, a Newton, Pa.-based clinical trials management company, and JLL Partners, a New York private equity firm, announced that they've successfully completed the tender offer by BC Acquisition Corp., an affiliate of JLL Partners that last month began a $7.25 per share offer for all outstanding shares of BioClinica. In January, JLL agreed to acquire BioClinica for $123 million.

DealsNorth AmericaUSBriefs